2023
DOI: 10.3390/ijms241411236
|View full text |Cite
|
Sign up to set email alerts
|

Glycine: The Smallest Anti-Inflammatory Micronutrient

Karla Aidee Aguayo-Cerón,
Fausto Sánchez-Muñoz,
Rocío Alejandra Gutierrez-Rojas
et al.

Abstract: Glycine is a non-essential amino acid with many functions and effects. Glycine can bind to specific receptors and transporters that are expressed in many types of cells throughout an organism to exert its effects. There have been many studies focused on the anti-inflammatory effects of glycine, including its abilities to decrease pro-inflammatory cytokines and the concentration of free fatty acids, to improve the insulin response, and to mediate other changes. However, the mechanism through which glycine acts … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 151 publications
(216 reference statements)
0
12
0
Order By: Relevance
“…55.7 mg, 66% yield, R f = 0.6, PE/EtOAc = 25:1, yellow oil; 1 H NMR (400 MHz, CDCl 3 ) δ 7.61 (d, J = 7.5 Hz, 4H), 7.46 (t, J = 7.1 Hz, 2H), 7.39 (d, J = 7.3 Hz, 3H), 7.01 (t, J = 7.3 Hz, 1H), 6.54 (d, J = 7.5 Hz, 1H), 6.30 (d, J = 7.6 Hz, 2H), 4.13−4.01 (m, 3H), 2.92 (s, 2H), 2.21 (s, 3H), 1.22 (t, J = 7.1 Hz, 3H); 19 F NMR (377 MHz, CDCl 3 ) δ −89.00 (d, J = 37.8 Hz), −89.34 (d, J = 37.9 Hz); 13 C { 1 H} NMR (100 MHz, CDCl 3 ) δ 173. 2,154.7 (dd,J = 289.7,287.0 Hz),146.4,140.7,140.6,139.2,131.7 (t,J = 3.5 Hz),129.3,129.0,127.7,127.4,127.2,119.6,114.5,110.9,88.9 Ethyl 4-( [1,-4-yl)-5,5-difluoro-2-(mesitylamino)pent-4-enoate (3e). 34.9 mg, 39% yield, R f = 0.6, PE/EtOAc = 25:1, colorless oil; 1 H NMR (400 MHz, CDCl 3 ) δ 7.63 (t, J = 5.8 Hz, 4H), 7.48 (t, J = 7.2 Hz, 2H), 7.42−7.37 (m, 3H), 6.81−6.77 (m, 2H), 4.04−3.99 (m, 2H), 3.87 (t, J = 7.0 Hz, 1H), 2.92 (d, J = 6.4 Hz, 2H), 2.23−2.16 (m, 9H), 1.18 (t, J = 7.1 Hz, 3H); 19 F NMR (377 MHz, CDCl 3 ) δ −88.98 (d, J = 37.9 Hz), −89.28 (d, J = 37.8 Hz); 13 C { 1 H} NMR (100 MHz, CDCl 3 ) δ 174.3, 154.5 (dd, J = 290.2, 287.0 Hz), 141.0, 140.6 (d, J = 4.6 Hz), 131.8 (t, J = 3.6 Hz), 131.4,129.8,129.6,129.0 (d,J = 5.3 Hz), 128.9 (t, J = 2.9 Hz), 127.8,127.4,127.3,127.2,89.0 (dd,J = 20.9,15.4 Hz),61.2,58.5,32.5,20.7,18.7,14.2 Ethyl 4-( [1,-4-yl)-2-((4-chlorophenyl)amino)-5,5-difluoropent-4-enoate (3f).…”
Section: ■ Conclusionmentioning
confidence: 99%
See 4 more Smart Citations
“…55.7 mg, 66% yield, R f = 0.6, PE/EtOAc = 25:1, yellow oil; 1 H NMR (400 MHz, CDCl 3 ) δ 7.61 (d, J = 7.5 Hz, 4H), 7.46 (t, J = 7.1 Hz, 2H), 7.39 (d, J = 7.3 Hz, 3H), 7.01 (t, J = 7.3 Hz, 1H), 6.54 (d, J = 7.5 Hz, 1H), 6.30 (d, J = 7.6 Hz, 2H), 4.13−4.01 (m, 3H), 2.92 (s, 2H), 2.21 (s, 3H), 1.22 (t, J = 7.1 Hz, 3H); 19 F NMR (377 MHz, CDCl 3 ) δ −89.00 (d, J = 37.8 Hz), −89.34 (d, J = 37.9 Hz); 13 C { 1 H} NMR (100 MHz, CDCl 3 ) δ 173. 2,154.7 (dd,J = 289.7,287.0 Hz),146.4,140.7,140.6,139.2,131.7 (t,J = 3.5 Hz),129.3,129.0,127.7,127.4,127.2,119.6,114.5,110.9,88.9 Ethyl 4-( [1,-4-yl)-5,5-difluoro-2-(mesitylamino)pent-4-enoate (3e). 34.9 mg, 39% yield, R f = 0.6, PE/EtOAc = 25:1, colorless oil; 1 H NMR (400 MHz, CDCl 3 ) δ 7.63 (t, J = 5.8 Hz, 4H), 7.48 (t, J = 7.2 Hz, 2H), 7.42−7.37 (m, 3H), 6.81−6.77 (m, 2H), 4.04−3.99 (m, 2H), 3.87 (t, J = 7.0 Hz, 1H), 2.92 (d, J = 6.4 Hz, 2H), 2.23−2.16 (m, 9H), 1.18 (t, J = 7.1 Hz, 3H); 19 F NMR (377 MHz, CDCl 3 ) δ −88.98 (d, J = 37.9 Hz), −89.28 (d, J = 37.8 Hz); 13 C { 1 H} NMR (100 MHz, CDCl 3 ) δ 174.3, 154.5 (dd, J = 290.2, 287.0 Hz), 141.0, 140.6 (d, J = 4.6 Hz), 131.8 (t, J = 3.6 Hz), 131.4,129.8,129.6,129.0 (d,J = 5.3 Hz), 128.9 (t, J = 2.9 Hz), 127.8,127.4,127.3,127.2,89.0 (dd,J = 20.9,15.4 Hz),61.2,58.5,32.5,20.7,18.7,14.2 Ethyl 4-( [1,-4-yl)-2-((4-chlorophenyl)amino)-5,5-difluoropent-4-enoate (3f).…”
Section: ■ Conclusionmentioning
confidence: 99%
“…41.6 mg, 43% yield, R f = 0.5, PE/EtOAc = 25:1, yellow oil; 1 H NMR (400 MHz, CDCl 3 ) δ 7.85 (d, J = 7.7 Hz, 2H), 7.66−7.58 (m, 4H), 7.48 (t, J = 7.1 Hz, 2H), 7.40− 7.36 (m, 3H), 6.45 (d, J = 7.9 Hz, 2H), 4.62 (d, J = 8.5 Hz, 1H), 4.35−4.30 (m, 2H), 4.24−4.00 (m, 3H), 3.09−2.89 (m, 2H), 1.37 (t, J = 6.7 Hz, 3H), 1.24 (t, J = 7.0 Hz, 3H); 19 F NMR (377 MHz, CDCl 3 ) δ −88.64 (d, J = 37.2 Hz), −89.15 (d, J = 37.2 Hz); 13 C { 1 H} NMR (100 MHz, CDCl 3 ) δ 172. 2,166.8,154.7 (dd,J = 290.3,287.5 Hz),149.9,140.8,140.4,131.6,131.4 (t, J = 3.4 Hz), 129.0 (t, J = 2.7 Hz), 127.7,127.4,127.2,120.0,112.2,88.5 (dd,J = 21.1,16.2 Hz),61.8,60.5,54.5,53.6,31.2,14.6,14.2; HRMS (ESI-TOF) m/z: [M + H] + Calcd for C 28 H 28 F 2 NO 4 480.1981;Found 480.1976. Ethyl 4-([1,1′-Biphenyl]-4-yl)-5,5-difluoro-2-((4-(trifluoromethyl)phenyl)amino)pent-4-enoate (3j).…”
Section: ■ Conclusionmentioning
confidence: 99%
See 3 more Smart Citations